Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.
BACKGROUND: Role of immune system in protecting the host from cancer is well established. Growing cancer however subverts immune response towards Th2 type and escape from antitumor mechanism of the host. Activation of both innate and Th1 type response is crucial for host antitumor activity. In our p...
Main Authors: | Faiz Ahmad, Jiju Mani, Pawan Kumar, Seenu Haridas, Pramod Upadhyay, Sangeeta Bhaskar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3184142?pdf=render |
Similar Items
-
Type 1 interferon mediated signaling is indispensable for eliciting anti-tumor responses by Mycobacterium indicus pranii
by: Gargi Roy, et al.
Published: (2023-04-01) -
Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
by: Bindu Singh, et al.
Published: (2017-01-01) -
Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.
by: Bindu Singh, et al.
Published: (2019-01-01) -
“Mycobacterium indicus pranii” Is a Strain of Mycobacterium intracellulare
by: David C. Alexander, et al.
Published: (2015-05-01) -
Mycobacterium indicus pranii therapy suppresses systemic dissemination of tumor cells in B16F10 murine model of melanoma
by: Anush Chakraborty, et al.
Published: (2023-04-01)